Shopping Cart 0
Cart Subtotal
AED 0

Continuous Renal Replacement Therapy Market: Current Analysis and Forecast (2021-2027)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 18346

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 21282

Details

The Rise in the global incidence of AKI and increase in the demand for effective renal replacement therapy among ICU patients and initiatives undertaken by governments to increase the awareness about CRRT therapy along with the increase in the launch of advanced CRRT system area anticipated to fuel the Continuous Renal Replacement Therapy Market growth during the forecast period.

The growing worldwide incidence of AKI/AKF is, therefore, expected to increase the demand for CRRT. According to the International Society of Nephrology (INR), an estimated 13.3 million cases of AKI are registered annually worldwide. This is anticipated to boost the adoption of continuous renal replacement therapy at a rapid rate. With the rapid growth in the geriatric population globally, the prevalence of kidney-related diseases is expected to increase significantly. This, in turn, is expected to propel the growth of the CRRT market at a significant rate during the forecast period.

The new product launch and the strategic alliance sin the industry is creating an opportunity for the companies to grow. The companies are getting competitive edge by these alliances and launch. For instance: In 2020, Medtronic plc announced the launch of the Carpediem system, the first and only pediatric and neonatal acute dialysis system designed to treat patients weighing 2.5-10 kg (5.5-22 pounds) requiring renal replacement therapy.

Based on product, the market is segmented into Disposable, Machine, Dialysates, Renal Replacement fluid. Dialysate's segment is to capture largest market share during the forecast period. The largest market share of this segment is attributed to factors such growing demand for dialysates to remove undesired solutes and restoring the electrolytes and acid-base balance in the blood along with presence of well-established players with strong offerings in dialysates & replacement fluid.

Based on mode of patient, market is segmented into Adult, Pediatrics, Neonates. Adult segment dominated the continuous renal replacement therapy market in 2020 and witnessed the highest growth in forecast period.

Based on Modality, the market is segmented into SCUF, CVVH, CVVHD, CVVHDF. The CVVHDF is anticipated to witness the highest growth rate during the forecast period. The growing preference of CVVHDF modality among a nephrologist and critical care physician, and the advantages such as better clearance of medium-sized solutes as compared to hemodialysis (owing to the combination of hemofiltration with the continuous HD procedure), proper acid-base balance without additional intervention, and a significant reduction in CRRT-related phosphate depletion area likely to play strong role in supporting the growth of the segment in the coming years.

For a better understanding of the market penetration of the Continuous Renal Replacement Therapy market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of APAC), and Rest of World. North America constitutes a major market for disposable medical device sensor and generated revenue of USD XX billion in 2020 owing to the presence of well-established players in the region, emerging investment in healthcare R&D by players etc., However, the Asia Pacific region would grow at the highest CAGR during the forecast period.

Some of the major players operating in the Continuous Renal Replacement Therapy market are Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, NIKKISO CO., LTD., B. Braun Melsungen AG, Asahi Kasei Corporation, Toray Medical Co., Ltd. , Infomed SA, Medtronic plc, Nipro Corporation.

The global continuous renal replacement therapy market size is projected to reach USD XX billion by 2027 from USD XX billion in 2020, at a CAGR of XX % during the forecast period. Various factors such as rise in worldwide prevalence of AKI, Growing number of ICU patients with AKI and increasing incidence of sepsis, and growing clinical advantage of CRRT over intermittent blood purification are factors likely to boost the growth of the market.

READ MORE

Table Of Content

Scope

1 MARKET INTRODUCTION

1.1. Market Definitions

1.2. Objective of the Study

1.3. Limitation

1.4. Stake Holders

1.5. Currency Used in Report

1.6. Scope of the Global Continuous Renal Replacement Therapy Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Methodology for the Global Continuous Renal Replacement Therapy Market

2.1.1. Main Objective of the Global Continuous Renal Replacement Therapy Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET REVENUE

7 MARKET INSIGHTS BY PRODUCT

7.1. Disposable

7.2. Machine

7.3. Dialysates

7.4. Renal Replacement fluids

8 MARKET INSIGHTS BY MODALITY

8.1. SCUF

8.2. CVVH

8.3. CVVHD

8.4. CVVHDF

9 MARKET INSIGHTS BY PATIENT

9.1. Adult

9.2. Pediatrics

9.3. Neonates

10 MARKET INSIGHTS BY REGION

10.1. North America Continuous Renal Replacement Therapy Market

10.1.1. The U.S

10.1.2. Canada

10.1.3. Rest of North America

10.2. Europe Continuous Renal Replacement Therapy Market

10.2.1. Germany

10.2.2. France

10.2.3. U.K.

10.2.4. Spain

10.2.5. Italy

10.2.6. Rest of Europe

10.3. Asia Pacific Continuous Renal Replacement Therapy Market

10.3.1. China

10.3.2. Japan

10.3.3. India

10.3.4. Australia

10.3.5. Rest of Asia Pacific

10.4. Rest of the World Continuous Renal Replacement Therapy Market

11 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET DYNAMICS

11.1. Market Drivers

11.2. Market Challenges

11.3. Impact Analysis

12 LEGAL & REGULATORY FRAMEWORK

13 DEMAND AND SUPPLY SIDE ANALYSIS

13.1. Demand Side Analysis

13.2. Supply Side Analysis

13.2.1. Top Product Launches

13.2.2. Top Business Partnerships

13.2.3. Top Merger & Acquisitions

14 VALUE CHAIN ANALYSIS

15 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET OPPORTUNITIES

16 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET TRENDS & INSIGHTS

17 COMPETITIVE SCENARIO

17.1. Porter's Five forces analysis

17.1.1. Bargaining power of Supplier

17.1.2. Bargaining power of Buyer

17.1.3. Industry Rivalry

17.1.4. Availability of Substitute

17.1.5. Threat of new Entrants

18 COMPANY PROFILED

18.1. Baxter International Inc.

18.1.1. Key Facts

18.1.2. Business Description

18.1.3. Key Product/Services Offerings

18.1.4. Growth Strategy

18.1.5. SWOT Analysis

18.1.6. Key Financials

18.1.6.1. Revenue Split

18.1.6.2. Financial Overview of Medline Industries, Inc.

18.1.7. Recent Developments

18.1.7.1. Product Launch

18.1.7.2. Partnerships

18.1.7.3. Business Expansion and Investments

18.1.7.4. Merger and Acquisition

18.2. Fresenius Medical Care AG & Co. KGaA

18.3. NIKKISO Co. Ltd.

18.4. B. Braun Melsungen AG

18.5. Medtronic plc

18.6. Toray Medical Co. Ltd.

18.7. Infomed SA

18.8. Nipro Corporation

19 DISCLAIMER

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Baxter International Inc.

Fresenius Medical Care AG & Co. KGaA

NIKKISO CO.

LTD.

B. Braun Melsungen AG

Asahi Kasei Corporation

Toray Medical Co.

Ltd.

Infomed SA

Medtronic plc

Nipro Corporation

Company Profile

Company Profile Title

The Rise in the global incidence of AKI and increase in the demand for effective renal replacement therapy among ICU patients and initiatives undertaken by governments to increase the awareness about CRRT therapy along with the increase in the launch of advanced CRRT system area anticipated to fuel the Continuous Renal Replacement Therapy Market growth during the forecast period.

The growing worldwide incidence of AKI/AKF is, therefore, expected to increase the demand for CRRT. According to the International Society of Nephrology (INR), an estimated 13.3 million cases of AKI are registered annually worldwide. This is anticipated to boost the adoption of continuous renal replacement therapy at a rapid rate. With the rapid growth in the geriatric population globally, the prevalence of kidney-related diseases is expected to increase significantly. This, in turn, is expected to propel the growth of the CRRT market at a significant rate during the forecast period.

The new product launch and the strategic alliance sin the industry is creating an opportunity for the companies to grow. The companies are getting competitive edge by these alliances and launch. For instance: In 2020, Medtronic plc announced the launch of the Carpediem system, the first and only pediatric and neonatal acute dialysis system designed to treat patients weighing 2.5-10 kg (5.5-22 pounds) requiring renal replacement therapy.

Based on product, the market is segmented into Disposable, Machine, Dialysates, Renal Replacement fluid. Dialysate's segment is to capture largest market share during the forecast period. The largest market share of this segment is attributed to factors such growing demand for dialysates to remove undesired solutes and restoring the electrolytes and acid-base balance in the blood along with presence of well-established players with strong offerings in dialysates & replacement fluid.

Based on mode of patient, market is segmented into Adult, Pediatrics, Neonates. Adult segment dominated the continuous renal replacement therapy market in 2020 and witnessed the highest growth in forecast period.

Based on Modality, the market is segmented into SCUF, CVVH, CVVHD, CVVHDF. The CVVHDF is anticipated to witness the highest growth rate during the forecast period. The growing preference of CVVHDF modality among a nephrologist and critical care physician, and the advantages such as better clearance of medium-sized solutes as compared to hemodialysis (owing to the combination of hemofiltration with the continuous HD procedure), proper acid-base balance without additional intervention, and a significant reduction in CRRT-related phosphate depletion area likely to play strong role in supporting the growth of the segment in the coming years.

For a better understanding of the market penetration of the Continuous Renal Replacement Therapy market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of APAC), and Rest of World. North America constitutes a major market for disposable medical device sensor and generated revenue of USD XX billion in 2020 owing to the presence of well-established players in the region, emerging investment in healthcare R&D by players etc., However, the Asia Pacific region would grow at the highest CAGR during the forecast period.

Some of the major players operating in the Continuous Renal Replacement Therapy market are Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, NIKKISO CO., LTD., B. Braun Melsungen AG, Asahi Kasei Corporation, Toray Medical Co., Ltd. , Infomed SA, Medtronic plc, Nipro Corporation.

The global continuous renal replacement therapy market size is projected to reach USD XX billion by 2027 from USD XX billion in 2020, at a CAGR of XX % during the forecast period. Various factors such as rise in worldwide prevalence of AKI, Growing number of ICU patients with AKI and increasing incidence of sepsis, and growing clinical advantage of CRRT over intermittent blood purification are factors likely to boost the growth of the market.

READ MORE

Scope

1 MARKET INTRODUCTION

1.1. Market Definitions

1.2. Objective of the Study

1.3. Limitation

1.4. Stake Holders

1.5. Currency Used in Report

1.6. Scope of the Global Continuous Renal Replacement Therapy Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Methodology for the Global Continuous Renal Replacement Therapy Market

2.1.1. Main Objective of the Global Continuous Renal Replacement Therapy Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET REVENUE

7 MARKET INSIGHTS BY PRODUCT

7.1. Disposable

7.2. Machine

7.3. Dialysates

7.4. Renal Replacement fluids

8 MARKET INSIGHTS BY MODALITY

8.1. SCUF

8.2. CVVH

8.3. CVVHD

8.4. CVVHDF

9 MARKET INSIGHTS BY PATIENT

9.1. Adult

9.2. Pediatrics

9.3. Neonates

10 MARKET INSIGHTS BY REGION

10.1. North America Continuous Renal Replacement Therapy Market

10.1.1. The U.S

10.1.2. Canada

10.1.3. Rest of North America

10.2. Europe Continuous Renal Replacement Therapy Market

10.2.1. Germany

10.2.2. France

10.2.3. U.K.

10.2.4. Spain

10.2.5. Italy

10.2.6. Rest of Europe

10.3. Asia Pacific Continuous Renal Replacement Therapy Market

10.3.1. China

10.3.2. Japan

10.3.3. India

10.3.4. Australia

10.3.5. Rest of Asia Pacific

10.4. Rest of the World Continuous Renal Replacement Therapy Market

11 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET DYNAMICS

11.1. Market Drivers

11.2. Market Challenges

11.3. Impact Analysis

12 LEGAL & REGULATORY FRAMEWORK

13 DEMAND AND SUPPLY SIDE ANALYSIS

13.1. Demand Side Analysis

13.2. Supply Side Analysis

13.2.1. Top Product Launches

13.2.2. Top Business Partnerships

13.2.3. Top Merger & Acquisitions

14 VALUE CHAIN ANALYSIS

15 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET OPPORTUNITIES

16 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET TRENDS & INSIGHTS

17 COMPETITIVE SCENARIO

17.1. Porter's Five forces analysis

17.1.1. Bargaining power of Supplier

17.1.2. Bargaining power of Buyer

17.1.3. Industry Rivalry

17.1.4. Availability of Substitute

17.1.5. Threat of new Entrants

18 COMPANY PROFILED

18.1. Baxter International Inc.

18.1.1. Key Facts

18.1.2. Business Description

18.1.3. Key Product/Services Offerings

18.1.4. Growth Strategy

18.1.5. SWOT Analysis

18.1.6. Key Financials

18.1.6.1. Revenue Split

18.1.6.2. Financial Overview of Medline Industries, Inc.

18.1.7. Recent Developments

18.1.7.1. Product Launch

18.1.7.2. Partnerships

18.1.7.3. Business Expansion and Investments

18.1.7.4. Merger and Acquisition

18.2. Fresenius Medical Care AG & Co. KGaA

18.3. NIKKISO Co. Ltd.

18.4. B. Braun Melsungen AG

18.5. Medtronic plc

18.6. Toray Medical Co. Ltd.

18.7. Infomed SA

18.8. Nipro Corporation

19 DISCLAIMER

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Baxter International Inc.

Fresenius Medical Care AG & Co. KGaA

NIKKISO CO.

LTD.

B. Braun Melsungen AG

Asahi Kasei Corporation

Toray Medical Co.

Ltd.

Infomed SA

Medtronic plc

Nipro Corporation